Edgestream Partners’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,974	Closed	-$151K	–	979
2024 Q4	$151K	Buy	+12,974	New	+$151K	0.01%	828
2024 Q1	–	Sell	-21,577	Closed	-$658K	–	960
2023 Q4	$658K	Buy	+21,577	New	+$658K	0.05%	545